Rachel King - Director, Novavax Inc

As of June 29, 2021


Rachel King Net Worth

  • Net worth is estimated to be at least $2.71M
  • Owns at least 3,900 units of Novavax Inc stock

Rachel King Trading

  • Largest purchase of shares was 700 units , worth over $97.75K on May 21, 2021
  • In total has made about 7 transactions over 3 years
  • Usually trades in June, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Rachel King Mailing Address

  • Mailing address is C/o Glycomimetics, Inc. 401 Professional Drive, Suite 250 Gaithersburg MD 20879 MD

Novavax Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Stanley C. Erck Stanley C. Erck 2020 $657,181 $48,086,018 $44,115,244 $48,086,018 $11,400 $48,086,018
Stanley C. Erck Stanley C. Erck 2019 $642,720 $2,438,562 $986,660 $2,438,562 $11,200 $2,438,562
Stanley C. Erck Stanley C. Erck 2018 $638,040 $4,158,398 $3,509,358 $4,158,398 $11,000 $4,158,398
Gregory F. Covino 2020 $55,000 $1,417,774 $659,967 $1,417,774 $8,032 $1,417,774
Gregory F. Covino 2019 $― $― $― $― $― $―
Gregory F. Covino 2018 $― $― $― $― $― $―
Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. 2020 $483,443 $24,923,376 $22,859,741 $24,923,376 $11,400 $24,923,376
Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. 2019 $470,453 $1,875,198 $819,421 $1,875,198 $11,200 $1,875,198
Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. 2018 $460,125 $1,681,456 $1,131,189 $1,681,456 $11,000 $1,681,456
John J. Trizzino John J. Trizzino 2020 $415,892 $21,327,954 $19,819,717 $21,327,954 $11,400 $21,327,954
John J. Trizzino John J. Trizzino 2019 $390,701 $1,465,602 $584,103 $1,465,602 $9,546 $1,465,602
John J. Trizzino John J. Trizzino 2018 $378,078 $1,329,776 $890,700 $1,329,776 $7,500 $1,329,776
John A. Herrmann III John A. Herrmann III 2020 $402,842 $20,606,814 $18,924,907 $20,606,814 $11,400 $20,606,814
John A. Herrmann III John A. Herrmann III 2019 $378,591 $1,353,416 $488,397 $1,353,416 $11,200 $1,353,416
John A. Herrmann III John A. Herrmann III 2018 $362,695 $1,137,576 $712,560 $1,137,576 $11,000 $1,137,576
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1000694/000110465921060332/tm212692d3_def14a.htm

Novavax Inc Insider Trading

  • The most recent transaction was 12,500 units sold on April 4, 2022 by James Young worth over $919.76K
  • In the last 19 years, insiders at Novavax Inc sold an estimated value of $286.68M and bought an estimated value of $38.15M
  • The most active traders are Gregory Glenn, President,  Gary Evans, Director,  and John A. Herrmann III, EVP
  • Insider trading is most common in March, with the busiest year in 2021
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1